DE602006013938D1 - Wirkstoff zur prävention/behandlung von erkrankungen infolge von acyclovir-resistentem herpesvirus - Google Patents

Wirkstoff zur prävention/behandlung von erkrankungen infolge von acyclovir-resistentem herpesvirus

Info

Publication number
DE602006013938D1
DE602006013938D1 DE602006013938T DE602006013938T DE602006013938D1 DE 602006013938 D1 DE602006013938 D1 DE 602006013938D1 DE 602006013938 T DE602006013938 T DE 602006013938T DE 602006013938 T DE602006013938 T DE 602006013938T DE 602006013938 D1 DE602006013938 D1 DE 602006013938D1
Authority
DE
Germany
Prior art keywords
acyclovir
aggregate
diseases
prevention
treatment
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006013938T
Other languages
English (en)
Inventor
Hiroshi Suzuki
Koji Chono
Kenji Sudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Astellas Pharma Inc
Original Assignee
Astellas Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astellas Pharma Inc filed Critical Astellas Pharma Inc
Publication of DE602006013938D1 publication Critical patent/DE602006013938D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42Oxazoles
    • A61K31/422Oxazoles not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4245Oxadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/20Antivirals for DNA viruses
    • A61P31/22Antivirals for DNA viruses for herpes viruses
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
DE602006013938T 2005-02-02 2006-02-01 Wirkstoff zur prävention/behandlung von erkrankungen infolge von acyclovir-resistentem herpesvirus Active DE602006013938D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2005027106 2005-02-02
PCT/JP2006/301616 WO2006082822A1 (ja) 2005-02-02 2006-02-01 アシクロビル耐性ヘルペスウイルスによる疾患の予防・治療剤

Publications (1)

Publication Number Publication Date
DE602006013938D1 true DE602006013938D1 (de) 2010-06-10

Family

ID=36777206

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006013938T Active DE602006013938D1 (de) 2005-02-02 2006-02-01 Wirkstoff zur prävention/behandlung von erkrankungen infolge von acyclovir-resistentem herpesvirus

Country Status (7)

Country Link
US (1) US20090048310A1 (de)
EP (1) EP1844776B1 (de)
JP (1) JPWO2006082822A1 (de)
CA (1) CA2596851A1 (de)
DE (1) DE602006013938D1 (de)
ES (1) ES2342558T3 (de)
WO (1) WO2006082822A1 (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2010047295A1 (ja) 2008-10-20 2012-03-22 アステラス製薬株式会社 帯状疱疹関連痛の予防又は治療薬

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1473157A (zh) * 2000-11-10 2004-02-04 ֮����ҩ��ʽ���� 酰胺衍生物
WO2003095435A1 (fr) * 2002-05-09 2003-11-20 Yamanouchi Pharmaceutical Co., Ltd. Derives d'amides
TW200505894A (en) * 2003-08-08 2005-02-16 Yamanouchi Pharma Co Ltd Tetrahydro-2H-thiopyran-4-carboxamide derivative

Also Published As

Publication number Publication date
JPWO2006082822A1 (ja) 2008-06-26
CA2596851A1 (en) 2006-08-10
EP1844776B1 (de) 2010-04-28
WO2006082822A1 (ja) 2006-08-10
ES2342558T3 (es) 2010-07-08
EP1844776A4 (de) 2008-09-03
US20090048310A1 (en) 2009-02-19
EP1844776A1 (de) 2007-10-17

Similar Documents

Publication Publication Date Title
ATE434620T1 (de) Dihydrothienopyrimidine zur behandlung von entzündlichen erkrankungen
DE602005007717D1 (de) Imidazolverbindungen zur behandlung von neurodegenerativen erkrankungen
DE602007004092D1 (de) C-met-proteinkinasehemmer zur behandlung proliferativer erkrankungen
ATE542823T1 (de) 4,5-dihydro-ä1,2,4ütriazoloä4,3-füpteridine als plk1-proteinkinasehemmer zur behandlung proliferativer erkrankungen
ATE549330T1 (de) Zur behandlung von erkrankungen des zns geeignete derivate des 4-piperazin-1-yl-4-benzoäbüthiophens
DE602005023172D1 (de) Hydantoinderivate zur behandlung von entzündlichen erkrankungen
DE602006019838D1 (de) Piperazinsubstituierte benzothiophene zur behandlung von geisteskrankheiten
ATE369333T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE375977T1 (de) Sulfonamidderivate zur behandlung von krankheiten
ATE550338T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
ATE429218T1 (de) Pinolensäure zur behandlung von übergewicht
ATE476414T1 (de) Biphenyloxyessigsäurederivate zur behandlung von atemwegserkrankungen
ATE447551T1 (de) Biphenyloxyessigsäure - derivate zur behandlung von atemwegserkränkungen
ATE534633T1 (de) Indazolderivate zur behandlung von hsp90- induzierten krankheiten
ATE440866T1 (de) Nogo-a-neutralisierende immunglobuline zur behandlung neurologischer krankheiten
ATE521365T1 (de) Kinin-antagonisten zur behandlung von blasenfunktionsstörung
ATE512948T1 (de) Biphenyl-sulfonyl- und phenyl-heteroaryl-sulfonyl-modulatoren des histamin-h3-rezeptors zur behandlung von damit verbundenen erkrankungen
ATE482709T1 (de) Neue arzneimittelkombinationen zur behandlung von atemwegserkrankungen
FI20095600A (fi) Koostumus ihosairauksien hoitoa varten
DE602005016141D1 (de) S-mirtazapin zur behandlung von hitzewallungen
ATE517877T1 (de) Neue arzneimittel zur behandlung von atemwegserkrankungen
ATE504297T1 (de) Visnadin zur behandlung von kopfhautjucken
ATE525355T1 (de) 1-ä(4-äbenzoyl(methyl)aminoü-3- (phenyl)butylüazetidinderivate zur behandlung von gastrointestinalen erkrankungen 1
DE602007009877D1 (de) Isosorbid-mononitrat-derivate zur behandlung von darmerkrankungen
ATE448228T1 (de) Pyrrolopyrimidinderivate zur behandlung proliferativer krankheiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition